(Q58218205)

2

0 references

Rafael Marcos-Gragera

object named as

Rafael Marcos-Gragera

4

0 references

author name string

Claudia Allemani

1

0 references

Jan Willem Coebergh

Cancer survival in Britain. Cancer chemotherapy costs money

5

0 references

language of work or name

English

0 references

publication date

2006

0 references

published in

Cancer

0 references

volume

107

0 references

issue

2

0 references

page(s)

352-360

0 references

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21995

"Inaccuracy' in death certification--where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21995

EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21995

7 January 2021

Combination Chemotherapy in the Treatment of Advanced Hodgkin's Disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21995

7 January 2021

Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21995

7 January 2021

Cancer survival corrected for heterogeneity in patient withdrawal.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21995

7 January 2021

Regression models for relative survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21995

7 January 2021

A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21995

7 January 2021

Hodgkin's disease: A correlation of histopathology with survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21995

7 January 2021

Correlation of histopathology with other prognostic indicators in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21995

7 January 2021

Age-specific survival after Hodgkin's disease in a population-based cohort (United States).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21995

7 January 2021

Improved survival of Hodgkin's patients in south-east Netherlands since 1972

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21995

7 January 2021

Cancer survival in Britain. Diagnosis in primary care is important

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21995

7 January 2021

Lymphocyte-rich classical Hodgkin's lymphoma: clinical presentation and treatment outcome in 100 patients treated within German Hodgkin's Study Group trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21995

7 January 2021

Expert review of the diagnosis and histologic classification of Hodgkin disease in a population-based cancer registry: interobserver reliability and impact on incidence and survival rates

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21995

7 January 2021

Age-dependent inaccuracy of asthma death certification in Northern England, 1991-1992

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21995

7 January 2021

Trend of cervical cancer mortality in Belgium (1954-1994): tentative solution for the certification problem of unspecified uterine cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21995

7 January 2021

Hodgkin disease in the elderly. A registry-based analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21995

7 January 2021

Prognostic factors in Hodgkin's disease with special reference to age

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21995

7 January 2021

Epstein-Barr virus and Hodgkin's disease: further evidence for the three disease hypothesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21995

7 January 2021

The immune system in the elderly: III. Innate immunity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21995

7 January 2021

Independent prognostic effect of co-morbidity in lymphoma patients: results of the population-based Eindhoven Cancer Registry

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21995

7 January 2021

Hodgkin's disease in patients older than 70 years of age: a registry-based analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21995

7 January 2021

VEPEMB in elderly Hodgkin's lymphoma patients. Results from an Intergruppo Italiano Linfomi (IIL) study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21995

7 January 2021

https://api.crossref.org/works/10.1002%2FCNCR.21995

1 reference

7 January 2021

Role of hematotoxicity and sex in patients with Hodgkin's lymphoma: an analysis from the German Hodgkin Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21995

7 January 2021

An analysis of prognostic factors in stage III and IV Hodgkin's disease treated at a single centre with MVPP

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21995

7 January 2021